UNC Health is putting significantly more money behind the venture capital operation that began at Rex Healthcare more than a decade ago, renaming Rex Health Ventures as UNC Health Ventures $125 million platform now positioned to invest in health care startups over the next decade.
How UNC Health Ventures $125 Million Funding Compares to Its Origins
Rex Health Ventures was created in 2012 with $10 million to invest in emerging health care companies, initially with a strong focus on the Triangle region. The new $125 million commitment represents a dramatic expansion from those origins, with the capital drawn from reallocated capital reserves within UNC Health’s broader investment portfolio rather than an outside fundraise.
Who Leads This Expanded Investment Platform
Anita Watkins, who leads UNC Health’s venture capital efforts, said the health system plans to invest around $125 million in startups over the next decade. The expanded platform is co-managed by Watkins and fellow managing director John Perez, alongside a 10-member investment committee made up of campus officials who evaluate technologies alongside health system executives.
The Portfolio Behind This UNC Health Ventures $125 Million Expansion
Rex Health Ventures invested in a total of 30 companies over its 14-year history, and UNC Health Ventures currently holds 12 active companies in its portfolio, including Reprieve Cardiovascular, a company developing therapy to remove excess fluid from patients with heart failure. Rex was among several funds that helped Reprieve raise $61 million in 2025 and begin enrolling patients in a clinical trial.
Why Reprieve Cardiovascular Illustrates the Fund’s Approach
A UNC Health spokesperson noted that the fund’s support extends well beyond capital, providing clinical collaboration, strategic insight, and real-world experience, a description Reprieve Cardiovascular’s own funding and trial progress appears to bear out as a concrete example of this hands-on investment model in practice.
Why UNC Health Ventures $125 Million Reflects a Broader Geographic Shift
Rex Health Ventures spent most of its history focused on investing in startups within the Triangle region, but that scope has now expanded well beyond it. UNC Health Ventures is agnostic about where its portfolio companies are based, though the system says it invests in companies that could improve outcomes for patients across North Carolina, and the fund still considers ideas and technologies developed by physicians and nurses within the UNC system itself.
Why This Expanded Mandate Makes Sense Strategically
Broadening the fund’s geographic scope while still prioritizing internally generated physician and nurse innovations allows UNC Health Ventures to pursue the strongest available investment opportunities nationally while maintaining a direct pipeline to homegrown clinical technologies developed within its own system.
Leadership’s Rationale Behind This UNC Health Ventures $125 Million Commitment
“Novel technologies are essential to advancing the care we provide to our patients and communities,” said Cristy Page, UNC Health’s CEO and dean of the UNC School of Medicine. UNC Health Chief Financial Officer Will Bryant said the platform is intended to create both long-term financial value and improvements in care and operations.
A Track Record of Returns Exceeding Investment
A UNC Health spokesperson said returns from the predecessor fund have exceeded investments, with more than half of the capital still deployed in active companies, giving the expanded $125 million commitment a demonstrated financial track record to build upon rather than an unproven investment thesis.
What This UNC Health Ventures $125 Million Commitment Means Going Forward
With the platform’s headquarters remaining at UNC Health Rex in Raleigh even as its investment mandate expands statewide and nationally, UNC Health Ventures appears positioned to significantly scale its startup investment activity while preserving the clinical collaboration model that has characterized its approach since 2012. Given the strong prior returns and Reprieve Cardiovascular’s successful $61 million raise and clinical trial progress, this expanded fund may attract increased attention from health tech startups seeking not just capital but also direct access to a major academic health system’s clinical and research infrastructure.
What to Watch Going Forward
As UNC Health Ventures begins deploying its expanded $125 million over the coming decade, industry observers will likely watch which specific health technology categories, medical devices, digital health, or emerging therapeutics, receive the largest share of new investment. Given the fund’s continued interest in physician- and nurse-originated ideas alongside its broader geographic mandate, this UNC Health Ventures $125 million platform may offer a useful model for how other academic health systems balance internal innovation pipelines against external, nationally competitive startup investment opportunities.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
